At the time of writing, Cytosorbents Corp [CTSO] stock is trading at $1.03, down -0.96%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CTSO shares have gain 9.84% over the last week, with a monthly amount glided 13.22%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cytosorbents Corp [NASDAQ: CTSO] stock has seen the most recent analyst activity on September 07, 2023, when B. Riley Securities initiated its Buy rating and assigned the stock a price target of $4. On September 17, 2020, Jefferies initiated with a Buy rating and assigned a price target of $15 on the stock. SVB Leerink started tracking the stock assigning a Outperform rating and suggested a price target of $15 on September 01, 2020. Maxim Group reiterated its recommendation of a Buy and raised its price target to $12 on August 08, 2017. In a note dated May 24, 2016, Maxim Group initiated an Buy rating and provided a target price of $8 on this stock.
For the past year, the stock price of Cytosorbents Corp fluctuated between $0.70 and $1.59. Cytosorbents Corp [NASDAQ: CTSO] shares were valued at $1.03 at the most recent close of the market.
Analyzing the CTSO fundamentals
According to Cytosorbents Corp [NASDAQ:CTSO], the company’s sales were 37.74M for trailing twelve months, which represents an 6.58% jump. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -0.0%, Pretax Profit Margin comes in at -0.27%, and Net Profit Margin reading is -0.27%. To continue investigating profitability, this company’s Return on Assets is posted at -49.17, Equity is -130.69 and Total Capital is -0.55. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0135 points at the first support level, and at 0.9969 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.0431, and for the 2nd resistance point, it is at 1.0561.
Ratios To Look Out For
It is important to note that Cytosorbents Corp [NASDAQ:CTSO] has a current ratio of 1.97. Further, the Quick Ratio stands at 1.58, while the Cash Ratio is 0.67. Considering the valuation of this stock, the price to sales ratio is 1.50, the price to book ratio is 4.32.
Transactions by insiders
Recent insider trading involved MARIANI PETER J, Chief Financial Officer, that happened on Dec 13 ’24 when 20000.0 shares were purchased. Chief Financial Officer, MARIANI PETER J completed a deal on Dec 12 ’24 to buy 20000.0 shares. Meanwhile, Chief Financial Officer MARIANI PETER J bought 11363.0 shares on Dec 11 ’24.
